Ritter Pharmaceuticals, Inc. develops and sells therapeutic products that modulate the gut microbiome to treat digestive disorders and gastrointestinal diseases. Its lead product candidate is RP-G28, an orally administered galacto-oligosaccharide that is in Phase III clinical trials for the treatment of lactose intolerance. The company was formerly known as Ritter Natural Sciences, LLC and changed its name to Ritter Pharmaceuticals, Inc. in Septe... View company details

MediPines is focused on creating innovative devices for respiratory diagnostics and managment. Our mission is to improve patient outcomes by empowering clinicians with non-invasive, practical solutions to the most significant respiratory challenges. We look for ways to make solutions that fit in with today's complicated healthcare practices View company details

Qualyst is a provider of hepatic drug metabolism, drug transporter products and contract research services. View company details

QuanDx develops and commercializes life science reagents and molecular diagnostic kits for applications in infection disease and bioterrorism testing. View company details

Quanta Aesthetic Lasers is a designer and manufacturer of lasers and light-based systems. View company details

Quanta BioDesign, Ltd. was founded for the purpose of developing and commercializing an extensive line of products for companies involved in drug discovery and diagnostic development programs. All of our products are based on our proprietary discrete polyethylene glycol (dPEG®) chemistries, including our processes for making these compounds. Our single molecular weight ethylene glycol conjugation technology, dPEG®, can eliminate common problems... View company details